1B1 Stock Overview
An investment holding company, provides medical services primarily in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
HC Surgical Specialists Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.29 |
| 52 Week High | S$0.31 |
| 52 Week Low | S$0.24 |
| Beta | 0.056 |
| 1 Month Change | 9.26% |
| 3 Month Change | 5.36% |
| 1 Year Change | 0% |
| 3 Year Change | -39.18% |
| 5 Year Change | -43.27% |
| Change since IPO | -46.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1B1 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -1.7% | -1.7% | 1.1% |
| 1Y | 0% | -9.9% | 15.4% |
Return vs Industry: 1B1 exceeded the SG Healthcare industry which returned -10.4% over the past year.
Return vs Market: 1B1 underperformed the SG Market which returned 15.1% over the past year.
Price Volatility
| 1B1 volatility | |
|---|---|
| 1B1 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in SG Market | 12.4% |
| 10% least volatile stocks in SG Market | 1.9% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine 1B1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Sieu Min Heah | www.hcsurgicalspecialists.com |
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services.
HC Surgical Specialists Limited Fundamentals Summary
| 1B1 fundamental statistics | |
|---|---|
| Market cap | S$45.37m |
| Earnings (TTM) | S$3.78m |
| Revenue (TTM) | S$19.38m |
12.0x
P/E Ratio2.3x
P/S RatioIs 1B1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1B1 income statement (TTM) | |
|---|---|
| Revenue | S$19.38m |
| Cost of Revenue | S$9.92m |
| Gross Profit | S$9.46m |
| Other Expenses | S$5.69m |
| Earnings | S$3.78m |
Last Reported Earnings
Nov 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.025 |
| Gross Margin | 48.83% |
| Net Profit Margin | 19.48% |
| Debt/Equity Ratio | 3.8% |
How did 1B1 perform over the long term?
See historical performance and comparisonDividends
5.1%
Current Dividend Yield61%
Payout RatioDoes 1B1 pay a reliable dividends?
See 1B1 dividend history and benchmarks| HC Surgical Specialists dividend dates | |
|---|---|
| Ex Dividend Date | Feb 28 2025 |
| Dividend Pay Date | Mar 13 2025 |
| Days until Ex dividend | 26 days |
| Days until Dividend pay date | 39 days |
Does 1B1 pay a reliable dividends?
See 1B1 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 13:00 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/11/30 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HC Surgical Specialists Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|